Virbac EquiMAX Evelation

Triple-Active Broad-Spectrum Horse Wormer Paste

Virbac Equimax Elevation is a broad-spectrum oral wormer combining Ivermectin, Praziquantel and Pyrantel for the treatment and control of roundworms, tapeworms and bots in horses — with a particular focus on protecting young horses from mectin-resistant ascarids.

Designed to treat susceptible roundworms (including arterial larval stages of Strongylus vulgaris and benzimidazole-resistant small strongyles), all three species of equine tapeworm and all three species of bots, as well as skin lesions caused by Habronema and Draschia spp. (summer sores) and Onchocerca spp. microfilariae (cutaneous onchocerciasis).

Supplied in a 23.1 mL apple-flavoured oral paste syringe that treats a horse weighing up to 700 kg, allowing accurate dosing according to bodyweight.

Why Three Actives?

Equimax Elevation provides a double action against both nematodes and tapeworms through its combination of three actives. This double action is considered to help delay the onset of resistance to any one of the actives, and the product is registered to treat abamectin, moxidectin and ivermectin-resistant ascarids.

• Ivermectin – broad-spectrum control of roundworms and bots
• Pyrantel – additional roundworm activity, including ascarids
• Praziquantel – targeted tapeworm control

Protecting Young Horses

Foals and young horses have immature immune systems and are more susceptible to worms than older horses. Ascarids mainly affect horses under two years of age and can cause lung damage during migration as well as serious colic. As ascarids are the worm species showing resistance to the mectins, Virbac recommends a combination wormer such as Equimax Elevation for young horses, with use from 6 weeks of age.

Ideal For

• Foals and young horses from 6 weeks to 2 years of age
• Properties where mectin-resistant ascarids are a concern
• Broad-spectrum worming including tapeworms and bots
• Horses on strategic, resistance-aware parasite-management programs

Key Benefits

• Three active ingredients in one syringe
• Registered to treat abamectin, moxidectin and ivermectin-resistant ascarids
• Controls benzimidazole-resistant small strongyles
• Treats all three species of equine tapeworm
• Controls all three species of bots
• Also targets lungworms, intestinal threadworms, summer sores and neck threadworms
• Label-approved for foals, pregnant mares and breeding stallions
• Palatable apple-flavoured paste for easy administration
• One syringe treats up to 700 kg bodyweight
• Developed and made in Australia for Australian conditions

Directions

Administer orally at 3.3 mL per 100 kg bodyweight. One 23.1 mL syringe treats a horse weighing up to 700 kg. Accurate bodyweight estimation is important to ensure the correct dose is given.

Storage

Store below 30°C (room temperature), away from light.

Responsible Worming

Equimax Elevation should form part of a parasite-management program suited to the individual horse, property and parasite risk. A modern program may include:

• Faecal egg count (FEC) testing
• Accurate dosing according to bodyweight
• Pasture and manure management
• Strategic selection of worming actives
• Monitoring treatment effectiveness and resistance
• Veterinary advice when required

Complete Protection for Young Horses

Virbac Equimax Elevation delivers triple-active, broad-spectrum parasite control in a single palatable syringe — an ideal choice for foals and young horses where ascarid resistance is a concern.

Always read and follow the label directions before use. Keep out of reach of children and animals. Observe any withholding periods stated on the label, and consult your veterinarian or the manufacturer if your horse is unwell, very young, pregnant or on other treatment.